Infectious Diseases

Rebecca C. Brady, MD

Appointment

Assistant Professor of Pediatrics

Email

rebecca.brady@cchmc.org

Phone

513-636-4578

Fax

513-636-7655

Credentials

MD: University of Kentucky, Lexington, KY, 1988.

Residency: Internal Medicine/Pediatrics, University of Louisville, Louisville, KY.

Fellowships: Pediatric Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio; Adult Infectious Diseases, University of Cincinnati, Cincinnati, OH.

Certifications: Pediatrics, 1992, recertified 1999; Internal Medicine, 1993; Pediatric Infectious Diseases, 1997; Adult Infectious Diseases, 1997.

Position History

Sept. 2003 - present: Assistant Professor, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

April 1999 - August 2003: Research Instructor of Pediatrics, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

August 1997 - March 1999: Research Associate, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

July 1995 - July 1997: Fellowship in Adult Infectious Diseases, University of Cincinnati Hospitals, Cincinnati, Ohio.

July 1992 - June 1995: Fellowship in Pediatric Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

July 1988 - June 1992: Resident in Internal Medicine and Pediatrics, University of Louisville Hospitals, Louisville, Kentucky

Awards and Honors

Awarded, Best Doctors in America, 2008

Research

Cytomegalovirus and other viral infections

Publications, Most Recent

Dennehy PH, Brady RC, Halperin SA, Ward RL, Alvey JC, Fischer FH Jr., Innis BL, Rathfon H, Schuind A, De Vos B, for the North American Human Rotavirus Vaccine Study Group. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.The Pediatric Infectious Disease Journal 2005; 24:481-8.
Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL. Rapid licensure of a new, inactivated influenza vaccine in the United States.Human Vaccines 2005; 1:239-44.
de Bruyn G, Vargas-Cortez M, Warren T, Tyring SK, Fife KH, Lalezari J, Brady RC, Shahmanesh M, Kinghorn G, Beutner KR, Patel R, Drehobl MA, Horner P, Kurtz TO, McDermott S, Wald A, Corey L. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.Vaccine 2006; 24:914-20.
Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay M, Wolff M, She D, Cox MMJ. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.Journal of Infectious Diseases 2006; 193:1223-8.
Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.Journal of the American Medical Association 2007; 297:1577-82.
Couch RC, Winokur P, Brady RC, Belshe R, Chen WH, Cate TR, Sigurdardottir B, Hoeper A, Graham IL, Edelman R, He F, Nino D, Capellan J, Ruben FL. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.Vaccine 2007; 25:7656-63.